NewsEuropeThe Swiss Federal Commission Supports The Legalisation Of Cannabis

The Swiss Federal Commission Supports The Legalisation Of Cannabis


As reported in

The Swiss Federal Commission on Issues Related to Addiction and the Prevention of Non-Communicable Diseases (CFANT) expressed its support for the legalisation of cannabis in a press release from the Swiss Federal Council.

The Swiss parliamentary committees have already given the green light to the legalisation of cannabis , a regulation which would therefore go further than the current experiments in the controlled distribution of cannabis, which are slow to start due to quality issues.

‘The current cannabis policy is unsuitable’, says the CFANT, which also points to the health risks. To prevent consumers from being exposed to potentially dangerous products, ‘the cannabis market must be legalised and regulated’.

The simple decriminalisation of consumption, the possibility of growing at home or selling through the health system ‘does not constitute a credible alternative to the black market’. 

Nevertheless, underlines the commission, ‘nothing justifies encouraging the consumption of this medicine’, which should therefore not be promoted.

The commission is therefore positioning itself for the control of cannabis by making it accessible without advertising it.

Last year, the federal government announced its intention to relax the rules for medical cannabis and end cannabis prohibition. Last October, the Committee on Social Security and Health of the Council of States recommended that Switzerland legalise cannabis.

Previously, the public health commission of the National Council in Switzerland had given its approval. The government must now start drafting a bill, but it has decided to experiment first.

If the Basel and Zurich experiments have been postponed, in the first case because pesticide residues were found in the soil, the number of participating cities will lead to an experimental network that could facilitate the implementation of a federation-wide legalisation of cannabis.

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Proposed Changes To Germany’s Medical Cannabis Framework Would ‘Seriously Impact Both Patients And Industry’ If Brought In Tomorrow

TOMORROW, Germany’s Federal Joint Committee (G-BA) is expected to announce major changes to the country’s medical cannabis framework.  These could...

Will Twitter’s ‘Relaxation’ On Cannabis Advertising Help Break The Industry’s Social Media Ad Embargo?

TWITTER has become the first major social media platform to openly allow the advertisement of cannabis brands.  Since the new...

Kanabo Launches New Online Medical Cannabis Clinic ‘Treat It’, Offering Access To Doctors In ‘Less Than 24 Hours’

KANABO Group has today announced the launch of a new online medical cannabis clinic for pain management, Treat It.  The...

Must read

You might also likeRELATED
Recommended to you